News Releases

News and information from The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Certain Patients with Mantle Cell Lymphoma

For Immediate Release
Contact: Andrea Greif
914-821-8958
andrea.greif@lls.org

(White Plains, NY) - November 13, 2013 - Today's U.S. Food and Drug Administration (FDA) approval of ibrutinib to treat patients with mantle cell lymphoma (MCL) is a significant advance for patients with this blood cancer.

It was approved as a single agent for treatment of patients with MCL...

Cancer Research Funded by The Leukemia & Lymphoma Society Featured in New PBS Documentary Series


To view the entire multi-media release, click here. Contact: Marcie Klein
(914) 821-8205
marcie.klein@lls.org White Plains, NY (February 23, 2015) - Significant advances toward cures for blood cancer patients, many of which were funded by The Leukemia & Lymphoma Society (LLS) over the past 65 years, are among the dramatic highlights featured in Ken Burns presents CANCER: THE E...

New Partnership Launches to Empower People Diagnosed with Lymphoma

For Immediate Release
Contact: Andrea Greif
 Phone: (914) 821-8958
Email:  andrea.greif@lls.org White Plains, NY (Feb. 10, 2015) - The Leukemia & Lymphoma Society (LLS) together with the Lymphoma Research Foundation (LRF), CancerCare, the Association of Community Cancer Centers (ACCC) and Genentech announced the launch of a new partnership, the Alliance for Resource Collaboration...

The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Patients with Waldenstrom's Macroglobulinemia

For Immediate Release
Contact: Andrea Greif
Senior Director of Communications
(914)821-8958 (p)
914)772-3027 (c)
andrea.greif@lls.org (White Plains, NY) - January 29, 2015  - Today's U.S. Food and Drug Administration (FDA) approval of ibrutinib (Imbruvica ®) to treat patients with Waldenstrom's macroglobulinemia(WM) is a significant advance for patients with this rare ...

The Leukemia & Lymphoma Society Announced as Winner of $100,000 Grant From the Hospira Foundation

For Immediate Release
Contact: Andrea Greif
(914) 821-8958
andrea.greif@lls.org White Plains, NY (Dec. 22, 2014) - The Leukemia & Lymphoma Society (LLS) has been selected to receive a $100,000 grant from the Hospira Foundation for its national Patient Travel Assistance Program, which assists patients around the country with treatment-related transportation and lodging financial challe...

The Leukemia & Lymphoma Society Applauds FDA Approval of Blinatumomab To Treat Patients with Acute Lymphoblastic Leukemia

For Immediate Release
Contact: Andrea Greif
Senior Director of Communications
(914)821-8958 (p)
914)772-3027 (c)
andrea.greif@lls.org White Plains, NY (December 3, 2014) - Today's U.S. Food and Drug Administration (FDA) approval of blinatumomab to treat patients with an uncommon form of acute lymphoblastic leukemia is a significant advance for patients with this form of bloo...

Research Funded by The Leukemia & Lymphoma Society Among Highlights at Annual American Society of Hematology

For Immediate Release
Contact: Andrea Greif
(914) 821-8958
andrea.greif@lls.org   White Plains, NY (December 1, 2014) - Many researchers funded by The Leukemia & Lymphoma Society (LLS) will be among those presenting innovative directions in blood cancer research at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition in San Francisco in early December. T...

Pages

Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: